1st ESCMID School of Clinical Microbiology and Infectious Diseases 2002


6 - 12 July 2002, Lausanne, Switzerland

Organized by the ESCMID Education Commitee.

Summer School Director

  • Dr Giorgio Zanetti, Division of Infectious Diseases, CHUV, Lausanne, Switzerland

Educational Programme

No downloadable files available.

Antimicrobial chemotherapy and vaccines

  • New drugs for resistant Gram-positive bacteria. L. Martinez-Martinez (ES)
  • New therapeutic options for Aspergillus infections. J. Bille (CH)
  • Immunomodulation in chronic viral infections. Applications for treatment of HIV infection and viral hepatitis. G. Pantaleo (CH)
  • Conjugate anti-pneumococcal vaccine. K. Muehlemann (?)

Microorganisms and pathogenesis

  • VRE: mechanism of resistance, origin, and dissemination. T. Coque (ES)
  • S. aureus : virulence factors, fitness cost of resistance. P. Moreillon (CH)
  • Intracellular pathogenesis (Listeria sp, Shigella sp, mycobacteria). G Tran Van Nhieu (FR)
  • Mechanisms of latency in herpes viridae. P. Meylan (CH)

Major clinical syndromes : diagnostic and management strategies

  • Place of the determination of geno- or phenotypic resistance in the treatment of HIV infection. A. Telenti (CH)
  • Impact of resistance on malaria prophylaxis. B. Taylor (?)
  • New diagnostic techniques: real time PCR, multiplex PCR, automation in clinical microbiology. M. Altwegg (CH)
  • Non-antibiotic management of severe sepsis. T. Calandra (CH)
  • Corticosteroids in meningitis: evidence-based or consensus?. R. Nau (DE)
  • Bacteriuria and candiduria in specific populations. P. Munoz (ES)

Immunocompromised hosts

  • Prophylaxis in solid organ transplant recipients. I. Hoepelman (NL)
  • Epidemiology of P. carinii infection. P. Hauser (CH)
  • Ventilator-associated pneumonia: management strategies. J.Y. Fagon (FR)
  • Use of antifungal drugs in granulocytopenic cancer patients. P. Verweij (NL)

Epidemiology, Public Health

  • Optimal use of antibiotics in the community. C. Carbon (FR)
  • Optimal use of antibiotics in the hospital. G. Zanetti (CH)
  • Emerging diseases: European systems of alarm and management of public health crises. P. Sudre (CH)
  • Re-emerging disease: multi-drug resistant tuberculosis. F. Drobniewski (UK)